Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 55 of Q32 Bio Inc.'s SEC filings and found 5 warrant series, 4 convertibles, 1 ATM program, 3 shelf registrations and 5 completed offerings on file for QTTB. The latest dilution event on file is a registration statement on Jul 28, 2026. Analysis updated Nov 1, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
LRMRLarimar Therapeutics, Inc.
LYELLyell Immunopharma, Inc.
LCTXLineage Cell Therapeutics, Inc.
LXEOLexeo Therapeutics, Inc. Common Stock
OCGNOcugen, Inc.
BIOABioAge Labs Inc.
CAMPCAMP4 Therapeutics Corporation
FATEFate Therapeutics, Inc.
ABEOAbeona Therapeutics Inc.
CABACabaletta Bio, Inc.
IPSCCentury Therapeutics, Inc.
IFRXInflaRx N.V. Common Stock
GLSIGreenwich LifeSciences, Inc.
IMRXImmuneering Corporation
FULCFulcrum Therapeutics, Inc.